NEWS

Santhera Pharmaceuticals Holding to raise capital through sale of newly created shares

Friday, Jul 31, 2015

Santhera Pharmaceuticals Holding AG to raise capital through sale of newly created shares.

Announces intent to sell up to 300,000 registered shares of newly created treasury shares (representing 6.03 pct of company's total outstanding share capital).

Proceeds will be used to finance commercial launch of raxone in leber's hereditary optic neuropathy in Europe.

Shares available-for-sale with a par value of 1.00 Swiss francs will be issued from company's conditional capital.

 

reuters.com

Other News